NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Synaptogenix Inc. Common Stock (NASDAQ: SNPX)
SNPX Technical Analysis
5
As on 9th Jun 2023 SNPX STOCK Price closed @ 0.85 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.88 & Strong Sell for SHORT-TERM with Stoploss of 7.97 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SNPXSTOCK Price
Open | 0.86 | Change | Price | % |
High | 0.88 | 1 Day | -0.01 | -1.16 |
Low | 0.82 | 1 Week | 0.01 | 1.19 |
Close | 0.85 | 1 Month | -0.05 | -5.56 |
Volume | 33124 | 1 Year | -8.01 | -90.41 |
52 Week High 10.09 | 52 Week Low 0.78 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
SNPX Daily Charts |
SNPX Intraday Charts |
Whats New @ Bazaartrend |
SNPX Free Analysis |
|
SNPX Important Levels Intraday
RESISTANCE | 0.97 |
RESISTANCE | 0.93 |
RESISTANCE | 0.91 |
RESISTANCE | 0.88 |
SUPPORT | 0.82 |
SUPPORT | 0.79 |
SUPPORT | 0.77 |
SUPPORT | 0.73 |
SNPX Forecast April 2024
4th UP Forecast | 8.69 |
3rd UP Forecast | 6.18 |
2nd UP Forecast | 4.62 |
1st UP Forecast | 3.07 |
1st DOWN Forecast | -1.37 |
2nd DOWN Forecast | -2.92 |
3rd DOWN Forecast | -4.48 |
4th DOWN Forecast | -6.99 |
SNPX Weekly Forecast
4th UP Forecast | 2.39 |
3rd UP Forecast | 1.90 |
2nd UP Forecast | 1.59 |
1st UP Forecast | 1.29 |
1st DOWN Forecast | 0.41 |
2nd DOWN Forecast | 0.11 |
3rd DOWN Forecast | -0.20 |
4th DOWN Forecast | -0.69 |
SNPX Forecast2024
4th UP Forecast | 20.02 |
3rd UP Forecast | 13.87 |
2nd UP Forecast | 10.07 |
1st UP Forecast | 6.27 |
1st DOWN Forecast | -4.57 |
2nd DOWN Forecast | -8.37 |
3rd DOWN Forecast | -12.17 |
4th DOWN Forecast | -18.32 |
Synaptogenix Inc. Common Stock ( NASDAQ USA Symbol : SNPX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SNPX Other Details
Segment | EQ | |
Market Capital | 64495580.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
SNPX Address
SNPX Latest News
SNPX Business Profile
Synaptogenix, Inc. operates as a biopharmaceutical company. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and niemann-pick type C disease. It has licensing agreements with Stanford University; Icahn School of Medicine; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is based in New York, New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service